Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 3
1985 2
1986 4
1987 3
1988 1
1989 1
1990 1
1991 2
1992 4
1993 6
1994 9
1995 16
1996 6
1997 18
1998 9
1999 12
2000 19
2001 9
2002 21
2003 40
2004 60
2005 62
2006 82
2007 100
2008 117
2009 161
2010 204
2011 205
2012 220
2013 262
2014 279
2015 366
2016 401
2017 426
2018 446
2019 505
2020 572
2021 588
2022 742
2023 794
2024 871
2025 1002
2026 427

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,062 results

Results by year

Filters applied: . Clear all
Page 1
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Woyach JA, Qiu L, Grosicki S, Wrobel T, Capra M, Czyz J, Yi S, Eom KS, Panovská A, Jurczak W, Laribi K, Jacobasch L, Baker R, Agajanian R, Berkovits A, Özcan M, Lepretre S, Coombs CC, Cramer P, Lewis KL, Hill M, Bao K, Bian Y, De Batista Ribeiro SR, Bhandari NR, Ruppert AS, Leow CC, Wierda WG. Woyach JA, et al. Among authors: qiu l. J Clin Oncol. 2026 Feb 20;44(6):476-485. doi: 10.1200/JCO-25-02477. Epub 2025 Dec 7. J Clin Oncol. 2026. PMID: 41353787 Free PMC article. Clinical Trial.
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.
Popat R, Beksac M, Dimopoulos MA, Gatt ME, Gay F, Jo JC, Kapoor P, Katodritou E, Kortüm KM, Ling S, Nagarajan C, Suzuki K, Qiu L, Onishi M, Ku G, Dail M, Mukherjee N, Ross JA, Badawi MA, Fusco MJ, Dobkowska E, Arriola E, Bueno OF, Bahlis NJ, Iida S, Moreau P, Valent J, Mateos MV. Popat R, et al. Among authors: qiu l. J Clin Oncol. 2026 Jan 20;44(3):164-175. doi: 10.1200/JCO-25-00924. Epub 2025 Dec 10. J Clin Oncol. 2026. PMID: 41370738 Free PMC article. Clinical Trial.
Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide.
Choi W, Nho YH, Qiu L, Chang A, Campos G, Seilheimer RL, Wilent WB, Bakalov D, Firdous N, Kerr M, Joshi D, Maze G, Topalovic U, Batista D, Suthana N, Amaro A, Hayes MR, Cajigas I, Cristancho M, Allison KC, Pesaran B, Scangos KW, Gold JI, Wadden TA, Halpern CH. Choi W, et al. Among authors: qiu l. Nat Med. 2025 Dec;31(12):4038-4043. doi: 10.1038/s41591-025-04035-5. Epub 2025 Nov 17. Nat Med. 2025. PMID: 41249493 Free PMC article.
DNA nanodevices detect an acidic nanolayer on the lysosomal surface.
Zhang Y, Hu M, Meng Y, Wang X, Huang F, Li P, Zhuo Y, Chen D, Wang Z, Zhang Q, Wu H, He Y, Du Y, Xu H, Qiu L, Tan W. Zhang Y, et al. Among authors: qiu l. Nat Cell Biol. 2026 Feb;28(2):285-295. doi: 10.1038/s41556-025-01855-y. Epub 2026 Jan 21. Nat Cell Biol. 2026. PMID: 41565777
8,062 results